Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
SFDA · 12 medicines · Historical list
AEMPS · 7 medicines
CBG-MEB · 6 medicines
AIFA · 4 medicines
PHARMAC · 4 medicines
MS · 4 medicines · Historical list
ALIMS · 4 medicines
FDA · 4 medicines
HSA · 3 medicines
EMA · 2 medicines
HALMED · 2 medicines
Every register, a page at a time. Strengths and packs are on each medicine’s page.
92 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Cytarabine | United States | 100MG/ML, 100MG/VIAL, 100MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** … | injectable | Marketed | Fresenius Kabi USA |
| Cytarabine DBL | New Zealand | Inj 100 mg per ml, 20 ml vial | Funded | ||
| Cytarabine Injection | Canada | 100 MG / ML | Solution | Marketed | Pfizer Canada Ulc |
| Cytarabine Injection | Canada | 100 MG / ML | Solution | Marketed | Sterimax INC |
| Cytarabine Accord 100 mg/ml, oplossing voor injectie of infusie | Netherlands | Oplossing voor injectie of infusie | Authorised | Accord Healthcare B.V. | |
| PMS-Cytarabine | Canada | 100 MG / ML | Solution | Marketed | Pharmascience INC |
| Cytarabine Solution for Injection 100 MG/ML | Singapore | 100 mg/ml | injection | Authorised | Pfizer Private Limited |
| Cytarabine Fresenius Kabi 100 mg/ml oplossing voor injectie of infusie | Netherlands | Oplossing voor injectie of infusie | Authorised | Fresenius Kabi Nederland B.V. | |
| Cytarabine Hospira 100 mg/5 ml Onco-Tain, oplossing voor injectie 20 mg/ml | Netherlands | Oplossing voor injectie | Authorised | Pfizer B.V. | |
| Cytarabine Hospira 1000 mg/10 ml Onco-Tain, concentraat voor oplossing voor infusie 100 mg/ml | Netherlands | Concentraat voor oplossing voor infusie | Authorised | Pfizer B.V. | |
| Cytarabine Hospira 2000 mg/20 ml Onco-Tain, concentraat voor oplossing voor infusie 100 mg/ml | Netherlands | Concentraat voor oplossing voor infusie | Authorised | Pfizer B.V. | |
| PMS-Cytarabine | Canada | 20 MG / ML | Solution | Not marketed | Pharmascience INC |
| Cytarabine 100MG-1ML Vial | Saudi Arabia | Authorised | Zydus Hospira Oncology Private Limited ZHOPL | ||
| Cytarabine 100MG-1ML Vial | Saudi Arabia | Authorised | Zydus Hospira Oncology Private Limited ZHOPL | ||
| Cytarabine 100MG-1ML Vial | Saudi Arabia | Authorised | Hospira Australia | ||
| Cytarabine 100MG-1ML Vial | Saudi Arabia | Authorised | Hospira Australia | ||
| Cytarabine Inj 100MG/ML | Canada | 100 MG / ML | Liquid | Cancelled | David Bull Laboratories (Pty) LTD. |
| Cytarabine Injection BP | Canada | 100 MG / ML | Solution | Cancelled | Sandoz Canada Incorporated |
| Cytarabine - PWS 1GN/Vial | Canada | 1 G / VIAL | Powder For Solution | Cancelled | Novopharm Limited |
| Cytarabine - PWS 2GM/Vial | Canada | 2 G / VIAL | Powder For Solution | Cancelled | Novopharm Limited |
| Cytarabine-PWS 100MG/Vial | Canada | 100 MG / VIAL | Powder For Solution | Cancelled | Novopharm Limited |
| Cytarabine - PWS 500MG/Vial | Canada | 500 MG / VIAL | Powder For Solution | Cancelled | Novopharm Limited |
| Cytarabine Injection, Mylan STD. | Canada | 100 MG / ML | Solution | Cancelled | Mylan Pharmaceuticals Ulc |
| Aj-Cytarabine | Canada | 100 MG / ML | Solution | Cancelled | Agila Jamp Canada INC |
| VyxeosCombination | United States | 100MG; 44MG | powder | Marketed | Jazz Pharms Therap |
The same brand on several registers.
The companies holding its medicines, the most first.
Substances it shares a medicine with.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, ALIMS, Anvisa, CBG-MEB, EMA, FDA, HALMED, Health Canada, HSA, MS, PHARMAC and SFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
